Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Abb Ltd's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Abb Ltd (ABBNY) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2023
Competitors Tracked
46
Publicly traded peers
Peer Group Market Share
16.73 %
vs 15.78 % a year ago
Revenue Growth Y/Y
9.47 %
Peers: 2.06 %
Net Margin
11.86 %
Peers: 29.74 %

Key Findings: Abb Ltd vs Its Competitors

  • TTM: Trailing 12-month revenue of 32,235M vs 712,774M combined for tracked competitors (4.3% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months), vs decelerating (-10.0%) for its tracked peer group.
  • Growth: Abb Ltd generated 9.5% revenue growth year over year in Q4 2023, vs 2.1% for its tracked competitors combined.
  • Profitability: Its 11.9% net margin compares with 29.7% for the peer group.
  • Scale: Abb Ltd ranks #1 of 38 companies by market capitalization in the Miscellaneous Manufacturing industry, holding 35.0% of industry market cap.
  • Peer revenue share: Abb Ltd accounted for 16.7% of combined revenue among its tracked peer group, up from 15.8% a year earlier.
  • Peer differentiation: Revenue per employee of $0.31M compares with $0.49M for the peer group (0.6x).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

ABBNY Sales vs. its Competitors, Q4 2023

Abb Ltd reported revenue growth of 9.47 % year on year in Q4 2023, above its competitors' combined revenue growth of 2.06 %.

With a net margin of 11.86 %, Abb Ltd reported lower profitability than its competitors (29.74 %).

Abb Ltd generated 16.73 % of the combined sales of its peer group, up from 15.78 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ABBNY/competitors
https://api.csimarket.com/api/v1/companies/ABBNY/relationships
https://api.csimarket.com/api/v1/companies/ABBNY/similar
Programmatic access for models, analytics, and integration workflows.

Abb Ltd vs. its Competitors, Q4 2023

Revenue growth, year on year

Abb Ltd +9.5 %
Competitors combined +2.1 %

Net income growth, year on year

Abb Ltd +47.4 %
Competitors combined +61.7 %

Net margin

Abb Ltd +11.9 %
Competitors combined +29.7 %

Revenue run-rate vs trailing 12 months

Abb Ltd +300.0 %
Competitors combined -10.0 %

TTM net margin

Abb Ltd +11.9 %
Competitors combined +18.0 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Abb Ltd and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Abb Ltd $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Similar-Size Competitors (5) $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Abb Ltd's competitor groups requires a Commercial License.

For context: the Miscellaneous Manufacturing industry grew revenue 9.7% year over year, combined, vs 9.5% for Abb Ltd. Abb Ltd's share of combined industry revenue moved from 41.75% to 41.68%, a loss of 0.07 percentage points.

Abb Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Abb Ltd - - - -
Competitors combined (45) 77% 84% 72% 20%
Similar-Size Competitors (5) 100% 100% 80% 40%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2023

16.7%market share
  • Abb Ltd16.7%
  • Competitors combined83.3%

Share of combined quarterly revenue of Abb Ltd and its 46 tracked competitors.

See Abb Ltd's full market share breakdown »

ABBNY Stock Performance relative to its Competitors

ABBNY Competitors (weighted) Percent change over the selected range

Abb Ltd's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
45%beat U.S.A. 500
Competitors Combined
(18 of 40)
0%beat U.S.A. 500
Similar-Size
(0 of 5)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Abb Ltd 39.50 % Outperformed
Competitors combined (40) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (5) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Abb Ltd's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

ABBNY Stock Performance relative to High-Confidence Competitors

ABBNY High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range

ABBNY Stock Performance relative to Similar-Size Competitors

ABBNY Similar-Size Competitors (equal-weighted, 5) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Orion Energy Systems Inc 282.9% Outperformed
2 Vishay Precision Group Inc 282.9% Outperformed
3 Powell Industries Inc 282.9% Outperformed
4 Bel Fuse Inc 282.9% Outperformed
5 Enersys 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Abb Ltd's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Abb Ltd's Comment on Competition and Industry Peers

The Board sets the Executive Committee (EC) compensation policy based on competitive market data, considering individual experience, performance, potential, and the market value of the role through compensation benchmarking. Comprehensive EC compensation benchmark reviews are conducted biennially, with the most recent review completed in 2022. Peer groups used for benchmarking are selected to match the size, scope, and complexity of ABB, excluding companies from the financial services sector.

Publicly Traded Peers of Abb Ltd

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Abb Ltd 185,169.06 32,235.00 3,824.00 105,000
General Electric Company 324,109.32 50,638.00 8,982.00 57,000
Eaton Corporation Plc 169,864.85 30,025.00 3,834.00 97,303
Danaher Corporation 151,468.86 25,107.00 4,004.00 60,000
Parker hannifin Corporation 124,583.65 21,499.00 3,649.00 59,850
Emerson Electric Co 90,679.37 18,637.00 2,579.00 73,000
SUBTOTAL 1,423,314.63 746,134.74 132,197.79 1,565,983
41 more competitors available

Sign in to see all competitors of Abb Ltd.

Sources: Abb Ltd's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Abb Ltd versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Abb Ltd's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
ABB Named by the company 85% 2022 to 2026 3
Powell Industries Inc Named by the company 85% 2022 to 2026 3
Chargepoint Holdings Inc Named by the company 85% 2022 to 2026 3
Aeternum Health Inc Named by the company 85% 2022 to 2026 3
Rockwell Automation Inc Named by the company 85% 2022 to 2026 3
Enersys Named by the company 85% 2022 to 2026 3
Vishay Precision Group Inc Named by the company 85% 2022 to 2026 3
American Superconductor Corp Named by the company 85% 2022 to 2026 3
Skkynet Cloud Systems Inc Named by the company 85% 2022 to 2026 3
Regal Rexnord Corp Named by the company 85% 2022 to 2026 3
Parker hannifin Corporation Named by the company 85% 2022 to 2026 3
General Electric Company Named by the company 85% 2022 to 2026 3
Danaher Corporation Named by the company 85% 2022 to 2026 3
Hubbell Inc Named by the company 85% 2022 to 2026 3
Honeywell International Inc Named by the company 85% 2022 to 2026 3
Hollysys Automation Technologies Ltd Named by the company 85% 2022 to 2026 3
Mueller Water Products Inc Named by the company 85% 2022 to 2026 3
Eaton Corporation Plc Named by the company 85% 2022 to 2026 3
Emerson Electric Co Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Abb Ltd's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.

Abb Ltd's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Abb Ltd Electrification 44.59 % Motion 22.62 % Process Automation 19.37 %
General Electric Company Commercial Engines and Services, Reportable 72.90 % Defense and Propulsion Technologies, Reportable 25.79 % -
Eaton Corporation Plc Electrical Americas 46.31 % Electrical Global 29.50 % Aerospace 14.32 %
Danaher Corporation Diagnostics 39.36 % Biotechnology 30.65 % Life Sciences 29.99 %
Parker hannifin Corporation Diversified Industrial 66.93 % Aerospace Systems 33.07 % -
Emerson Electric Co Safety and Productivity 11.33 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

25 more Peers available

Sign in to see all peers for Abb Ltd.

Abb Ltd's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Abb Ltd 185,169 307,000 36,419
General Electric Company 324,109 888,386 157,579
Eaton Corporation Plc 169,865 308,572 39,403
Danaher Corporation 151,469 418,450 66,733
Parker hannifin Corporation 124,584 359,215 60,969
Emerson Electric Co 90,679 255,301 35,329
PEERS TOTAL 1,238,146 488,643 87,868
41 more Peers available

Sign in to see all peers for Abb Ltd.

Abb Ltd's Geographic Revenue Exposure vs Peers

Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.
Company Largest Market 2nd Market 3rd Market
Abb Ltd Europe 35.89 % Americas 34.40 % Asia Middle East and Africa 29.71 %
Danaher Corporation North America 39.49 % High-growth markets 31.25 % Western Europe 24.58 %
Parker hannifin Corporation North America 67.21 % Europe 19.80 % Asia Pacific 11.99 %
Te Connectivity plc Asia Pacific 36.91 % EMEA 33.96 % Americas 29.13 %
Rockwell Automation Inc North America 64.07 % EMEA 17.47 % Asia Pacific 12.45 %
Idex Corp United States 50.74 % Europe 24.10 % Asia 16.97 %

Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.

19 more Peers available

Sign in to see all peers for Abb Ltd.

Abb Ltd's Position in Industry Market Structure

Market-capitalization share and concentration across all 35 companies in Abb Ltd's industry classification, broader than the peer set above. Market cap in millions of $.

Abb Ltd ranks #1 of 35 companies by market capitalization in its industry, holding 34.97 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 1,774, indicating a moderately concentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).

Rank Company Market Cap Industry Share
1 Abb Ltd 185,169 34.97 %
2 Trane Technologies Plc 103,220 19.49 %
3 Ferguson Enterprises Inc 43,326 8.18 %
4 Xylem Inc 24,081 4.55 %
5 Amcor Plc 1,234 5.2%
6 Snap on Inc 1,234 5.2%
7 Itt Inc 1,234 5.2%
8 Idex Corp 1,234 5.2%
9 Stanley Black and Decker Inc 1,234 5.2%
10 Graco Inc 1,234 5.2%
Full Industry Market Structure

Market cap and industry share for the rest of Abb Ltd's industry peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-10-02.

Abb Ltd's Same-Size Peers & Stock Performance

Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.
Rank Company Market Cap TTM Return 3M Momentum Beta Sharpe (1Y)
1 Abb Ltd 185,169 39.49 % -7.89 % 1.03 1.37
2 Trane Technologies Plc 103,220 9.10 % -1.67 % 1.03 0.29
3 Ferguson Enterprises Inc 1,234 12.3% 4.5% 1.10 0.80
4 Xylem Inc 1,234 12.3% 4.5% 1.10 0.80
5 Amcor Plc 1,234 12.3% 4.5% 1.10 0.80
6 Snap on Inc 1,234 12.3% 4.5% 1.10 0.80
Full Same-Size Peer Performance

Market cap, return, momentum, beta and Sharpe ratio for the rest of Abb Ltd's same-size peers requires a Commercial License.

Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-10-02. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.

Abb Ltd's BCG Growth-Share Matrix

Relative market share (vs Abb Ltd's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.

Question Mark Star Dog Cash Cow Relative Market Share (vs largest competitor) Industry Revenue Growth (%) Abb Ltd

Abb Ltd falls in the Cash Cow quadrant: relative market share of 1.79x vs its largest competitor, in an industry growing revenue 4.2% (median, trailing 12 months).

Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.

Abb Ltd's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.
Force Assessment Basis
Competitive Rivalry Moderate Industry HHI of 1,774 (see Industry Market Structure & Concentration above)
Supplier Power Not covered on this page See Abb Ltd's dedicated suppliers page for concentration and dependency data
Buyer Power Not covered on this page See Abb Ltd's dedicated customers page for concentration and dependency data
Threat of Substitutes - No systematic data source for cross-product substitution exists in this system; not estimated

Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.

Abb Ltd's Industry Attractiveness & Competitive Strength

A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.

High Strength
Medium Strength
Low Strength
High Attractiveness
Invest / Grow
Invest / Grow
Selective
Medium Attractiveness
Invest / Grow
Selective
Harvest
Low Attractiveness
Selective Abb Ltd
Harvest
Harvest / Divest

Abb Ltd falls in the Low attractiveness / High strength cell: Selective.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Abb Ltd's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

  • Market leader by capitalization in its industry (#1 of 35, 34.97 % share).
  • Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Outperforming the U.S.A. 500 over the trailing 12 months.

Weaknesses

No rule matched.

Opportunities

No rule matched.

Threats

  • Tracked peer group's revenue run-rate is broadly decelerating (-10.0% annualized).

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Abb Ltd's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Abb Ltd 0.22 1.18 1.34 0.79
General Electric Company - 0.86 1.09 0.39
Eaton Corporation Plc 0.05 1.25 0.79 0.62
Danaher Corporation - 1.73 0.40 0.30
Parker hannifin Corporation 0.08 1.16 0.65 0.71
Emerson Electric Co 0.05 0.88 0.65 0.44
41 more Peers available

Sign in to see all peers for Abb Ltd.

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Abb Ltd's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Abb LtdQ4 2023+9.5 %+9.5 %+47.4 %+47.4 %
General Electric CompanyQ2 2026+21.1 %+7.7 %+16.6 %+22.8 %
Eaton Corporation PlcQ2 2026+21.4 %+14.5 %-16.2 %-5.2 %
Danaher CorporationQ2 2026+5.5 %+5.3 %+56.8 %-15.5 %
Parker hannifin CorporationQ2 2026+9.8 %+4.9 %+18.2 %+20.8 %
Emerson Electric Co Q2 2026+7.0 %+6.8 %+22.5 %+16.2 %
PEERS TOTAL+10.1 %+7.4 %+80.5 %+103.9 %
41 more Peers available

Sign in to see all peers for Abb Ltd.

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Abb Ltd's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Abb LtdQ4 2023+6.5 %+6.5 %+1.0 %+1.0 %
General Electric CompanyQ2 2026+540.9 %+438.0 %+2.4 %+1.2 %
Eaton Corporation PlcQ2 2026+28.1 %+18.3 %+25.2 %+31.1 %
Danaher CorporationQ2 2026+10.0 %+12.5 %+8.5 %+13.5 %
Parker hannifin CorporationQ2 2026+6.8 %+1.1 %+32.2 %-
Emerson Electric Co Q2 2026+2.7 %+3.6 %+9.7 %-
41 more Peers available

Sign in to see all peers for Abb Ltd.

Abb Ltd's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Abb Ltd9.34%11.23%28.52%4.5410.05
General Electric Company6.98%11.25%48.50%4.292.34
Eaton Corporation Plc7.94%10.71%19.56%5.013.87
Danaher Corporation4.72%5.44%7.66%6.503.78
Parker hannifin Corporation11.99%15.10%25.38%7.104.37
Emerson Electric Co 6.13%8.71%12.69%6.003.72
41 more Peers available

Sign in to see all peers for Abb Ltd.

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Abb Ltd's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Abb Ltd49.445.74--13.81
General Electric Company36.556.401.14-18.14
Eaton Corporation Plc44.465.66-1,998.418.37
Danaher Corporation38.096.034.30108.892.88
Parker hannifin Corporation34.165.793.583,664.238.08
Emerson Electric Co 35.364.874.01-4.45
PEERS AVERAGE10.771.91-1.45
41 more Peers available

Sign in to see all peers for Abb Ltd.

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.

Get the full CSIMarket dataset: Subscribe API License